Development of Childhood Anti-Influenza Immunity

PHASE4CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

September 25, 2018

Primary Completion Date

December 22, 2020

Study Completion Date

December 22, 2020

Conditions
InfluenzaInfluenza Immunisation
Interventions
BIOLOGICAL

Influenza Virus Quadrivalent Inactivated Vaccine

A seasonal quadrivalent inactivated influenza vaccine (IIV4), prepared from influenza viruses propagated in embryonated chicken eggs, protecting against 2 influenza A subtypes (H1N1 and H3N3) and 2 influenza B subtypes (B Yamata lineage B Victoria lineage).

Trial Locations (1)

14642-0001

University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT03673345 - Development of Childhood Anti-Influenza Immunity | Biotech Hunter | Biotech Hunter